跳至主要内容
临床试验/ACTRN12624000991516
ACTRN12624000991516尚未招募3 期

A randomised, placebo controlled clinical trial of the efficacy of dexmedetomidine as part of a sleep promotion bundle on sleep quality in adults in intensive care who report a subjective sleep disturbance

South Metropolitan Health Service0 个研究点目标入组 72 人开始时间: 2024年8月13日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1.Adult patient aged 18 years or older admitted to the ICU
  • 2.Expected to remain in the ICU overnight from the time of enrollment.
  • 3.Capacity to complete a self-reported sleep assessment*
  • 4.Subjectively reported sleep disturbance during the current ICU admission**
  • * Absence of altered mental state and ability to understand sleep questions and provide responses
  • ** According to patient-reported survey (Richards-Campbell Sleep Questionnaire)

排除标准

  • 1.Contraindication to dexmedetomidine (including but not limited to allergy and bradycardia)
  • 2.Currently receiving dexmedetomidine
  • 3.Treating clinician believes study participation is not in the patient’s best interest
  • 4.Pregnancy or breastfeeding

研究者

相似试验